Title: Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis.
Citation: Eur J Intern Med
2022;95:61–66.
Country: Spain | Indication: EGPA
http://tago.ca/34535374
Title: Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis.
Citation: Eur J Intern Med
2022;95:61–66.
Country: Spain | Indication: EGPA
Title: Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis.
Citation: Eur J Intern Med
2022;95:61–66.
Country: Spain | Indication: EGPA